太空脑机接口实验落地！医疗器械ETF（562600）午盘跳水后震荡翻红涨0.51%，天智航-U涨超12%

Group 1 - The core viewpoint of the articles highlights the significant interest and investment in the medical device sector, particularly in brain-computer interface (BCI) technology, which is expected to commercialize by 2026 and expand into various fields beyond healthcare [1][2] - The medical device ETF (562600) has seen substantial capital inflow, with a net inflow of 91 million yuan over the past five days and 187 million yuan over the past ten days, indicating strong investor interest [1] - The brain-computer interface market is projected to grow to approximately $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17% from 2025 to 2034, driven by technological breakthroughs and policy support [2] Group 2 - The medical device ETF (562600) tracks the CSI All-Share Medical Device Index, with a notable 23.8% allocation to brain-computer interface technologies, the highest among similar ETFs, effectively capturing growth opportunities in this niche [2] - Major holdings in the ETF include industry leaders such as Mindray Medical and Dean Diagnostics, reflecting a concentrated focus on high-growth segments within the medical device industry [2]